EUVIMEDEUVIMED entdecken
Crossref

Cardiac α2δ1 C-terminal contributes to left atrial hypertrophy in chronic ischemic heart failure, in association with changes in membrane GluN1 and p-CAMKII/p-HDAC4 signaling

Shaoxian Wang, Zhenjun Li, Ning Yang, Jie Xu, Bo Yang, Zengxiang Dong, Xiaohui Zhou, Wei Han

Cell and Tissue Research · 2026-07 · 405 (1)

DOI: 10.1007/s00441-026-04086-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Tissue Research, online erschienen am 24.06.2026. Verfasst von Shaoxian Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Hauptthemen laut MEDLINE: Heart Failure, Histone Deacetylases, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Myocardial Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Key Discipline Construction Project of Shanghai Pudong New Area Health Commission, National Natural Science Foundation of China, Heilongjiang Provincial Natural Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left atrial remodeling (LAR) critically contributes to the progression of heart failure (HF) and the development of atrial fibrillation (AF) following myocardial infarction (MI). The protein α2δ1, primarily known for its role in neuropathic pain, is abundantly expressed in atrial tissue, but its involvement in post-MI LAR remains unclear. Here, LAR models were established in rats post-MI, and atrial hypertrophy was induced in HL-1 cells using angiotensin II (AngII). The role of α2δ1 in atrial hypertrophy was examined through treatment with either the α2δ1 inhibitor gabapentin or a C-terminal interfering peptide (α2δ1 CT-pep). A significant upregulation of α2δ1 expression was observed in the left atrium (LA) of MI rats and in AngII-treated HL-1 cells. Western blot analysis revealed increased α2δ1 levels in membrane fractions and decreased levels in the cytoplasmic fractions compared to controls. Both gabapentin and α2δ1 CT-pep treatment significantly reduced HL-1 cell hypertrophy and inhibited CAMKII and HDAC4 phosphorylation. Co-immunoprecipitation assays demonstrated an interaction between α2δ1 and GluN1, which was enhanced by AngII stimulation. Inhibition of α2δ1 attenuated the α2δ1-GluN1 interaction and reduced GluN1 translocation to the plasma membrane. In MI-induced HF rats, gabapentin treatment diminished atrial hypertrophy, suppressed AF inducibility and duration, and decreased membrane-associated α2δ1 and GluN1 levels. These findings suggest that the C-terminal domain of α2δ1 may contribute to left atrial hypertrophy in chronic ischemic heart failure and is associated with altered membrane GluN1 abundance and p-CAMKII/p-HDAC4 signaling. α2δ1 may therefore represent a potential therapeutic target for left atrial remodeling in ischemic heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHistone DeacetylasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Myocardial IschemiaReceptors, N-Methyl-D-AspartateCardiomegalyHeart AtriaCell MembraneAnimalsSignal TransductionMaleRatsRats, Sprague-DawleyChronic DiseasePhosphorylationCell LineCalcium Channels, L-Type

Stichwörter der Autor:innen

Atrial hypertrophyGabapentinGluN1Heart failureα2δ1

Substanzen

Histone DeacetylasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Receptors, N-Methyl-D-AspartateHDAC4 protein, ratCacna2d1 protein, ratCalcium Channels, L-Type

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Department of Echocardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. dongzx1982@163.com.
  • The Key Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. dongzx1982@…
  • Shanghai Heart Failure Research Center, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200120, China. zxh100@tongji.edu.cn.
  • Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. 2100504@tongji.edu.cn.

Förderung

  • Key Discipline Construction Project of Shanghai Pudong New Area Health Commission
  • National Natural Science Foundation of China
  • Heilongjiang Provincial Natural Science Fund

Zitieren

APA

Wang, S., Li, Z., Yang, N., Xu, J., Yang, B., Dong, Z., Zhou, X., & Han, W. (2026). Cardiac α2δ1 C-terminal contributes to left atrial hypertrophy in chronic ischemic heart failure, in association with changes in membrane GluN1 and p-CAMKII/p-HDAC4 signaling. Cell and Tissue Research, 405(1). https://doi.org/10.1007/s00441-026-04086-1

Vancouver

Wang S, Li Z, Yang N, Xu J, Yang B, Dong Z, et al. Cardiac α2δ1 C-terminal contributes to left atrial hypertrophy in chronic ischemic heart failure, in association with changes in membrane GluN1 and p-CAMKII/p-HDAC4 signaling. Cell and Tissue Research. 2026;405(1). doi:10.1007/s00441-026-04086-1

BibTeX
@article{Wang2026,
  author = {Wang, Shaoxian and Li, Zhenjun and Yang, Ning and Xu, Jie and Yang, Bo and Dong, Zengxiang and Zhou, Xiaohui and Han, Wei},
  title = {Cardiac α2δ1 C-terminal contributes to left atrial hypertrophy in chronic ischemic heart failure, in association with changes in membrane GluN1 and p-CAMKII/p-HDAC4 signaling},
  journal = {Cell and Tissue Research},
  year = {2026},
  volume = {405},
  number = {1},
  doi = {10.1007/s00441-026-04086-1}
}
Kostenlos starten →